Literature DB >> 1826882

Estimation of technetium 99m mercaptoacetyltriglycine plasma clearance by use of one single plasma sample.

R Müller-Suur1, G Magnusson, I Bois-Svensson, B Jansson.   

Abstract

Recent studies have shown that technetium 99m mercaptoacetyltriglycine (MAG-3) is a suitable replacement for iodine 131 or 123 hippurate in gamma-camera renography. Also, the determination of its clearance is of value, since it correlates well with that of hippurate and thus may be an indirect measure of renal plasma flow. In order to simplify the clearance method we developed formulas for the estimation of plasma clearance of MAG-3 based on a single plasma sample and compared them with the multiple sample method based on 7 plasma samples. The correlation to effective renal plasma flow (ERPF) (according to Tauxe's method, using iodine 123 hippurate), which ranged from 75 to 654 ml/min per 1.73 m2, was determined in these patients. Using the developed regression equations the error of estimate for the simplified clearance method was acceptably low (18-14 ml/min), when the single plasma sample was taken 44-64 min post-injection. Formulas for different sampling times at 44, 48, 52, 56, 60 and 64 min are given, and we recommend 60 min as optimal, with an error of estimate of 15.5 ml/min. The correlation between the MAG-3 clearances and ERPF was high (r = 0.90). Since normal values for MAG-3 clearance are not yet available, transformation to estimated ERPF values by the regression equation (ERPF = 1.86 x CMAG-3 + 4.6) could be of clinical value in order to compare it with the normal values for ERPF given in the literature.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1826882     DOI: 10.1007/bf00177681

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  12 in total

1.  Technetium-99m labeled renal function and imaging agents: II. Clinical evaluation of 99mTc MAG3 (99mTc mercaptoacetylglycylglycylglycine).

Authors:  B Bubeck; W Brandau; M Steinbächer; F Reinbold; K Dreikorn; M Eisenhut; P Georgi
Journal:  Int J Rad Appl Instrum B       Date:  1988

2.  Technetium-99m MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders.

Authors:  R A Jafri; K E Britton; C C Nimmon; K Solanki; A Al-Nahhas; J Bomanji; J Fettich; L A Hawkins
Journal:  J Nucl Med       Date:  1988-02       Impact factor: 10.057

3.  Quantitation of renal function with technetium-99m MAG3.

Authors:  C D Russell; B L Thorstad; M V Yester; M Stutzman; E V Dubovsky
Journal:  J Nucl Med       Date:  1988-12       Impact factor: 10.057

Review 4.  Quantitation of renal function with glomerular and tubular agents.

Authors:  E V Dubovsky; C D Russell
Journal:  Semin Nucl Med       Date:  1982-10       Impact factor: 4.446

5.  Estimation of technetium-99m-MAG3 plasma clearance in adults from one or two blood samples.

Authors:  C D Russell; A Taylor; D Eshima
Journal:  J Nucl Med       Date:  1989-12       Impact factor: 10.057

6.  A comparative study of renal scintigraphy and clearance with technetium-99m-MAG3 and iodine-123-hippurate in patients with renal disorders.

Authors:  R Müller-Suur; I Bois-Svensson; L Mesko
Journal:  J Nucl Med       Date:  1990-11       Impact factor: 10.057

7.  Determination of 99mTc-DTPA clearance by a single plasma sample method.

Authors:  A B Christensen; S Groth
Journal:  Clin Physiol       Date:  1986-12

8.  Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement.

Authors:  A R Fritzberg; S Kasina; D Eshima; D L Johnson
Journal:  J Nucl Med       Date:  1986-01       Impact factor: 10.057

9.  Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.

Authors:  A Taylor; J A Ziffer; A Steves; D Eshima; V B Delaney; J D Welchel
Journal:  Radiology       Date:  1989-03       Impact factor: 11.105

10.  Renal and extrarenal handling of a new imaging compound (99m-Tc-MAG-3) in the rat.

Authors:  R Müller-Suur; C Müller-Suur
Journal:  Eur J Nucl Med       Date:  1986
View more
  5 in total

1.  Assessment of effective renal plasma flow, enzymuria, and cytokine release in healthy volunteers receiving a single dose of amphotericin B desoxycholate.

Authors:  Manjunath P Pai; Jeffrey P Norenberg; Robert A Telepak; David S Sidney; Shu Yang
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

2.  Flow rate models in renal obstruction.

Authors:  J P Coffey
Journal:  World J Urol       Date:  2010-05-29       Impact factor: 4.226

3.  Renal effects of aspirin and low dose methotrexate in rheumatoid arthritis.

Authors:  P Seideman; R Müller-Suur
Journal:  Ann Rheum Dis       Date:  1993-08       Impact factor: 19.103

4.  First experience in healthy volunteers with technetium-99m L,L-ethylenedicysteine, a new renal imaging agent.

Authors:  C G Van Nerom; G M Bormans; M J De Roo; A M Verbruggen
Journal:  Eur J Nucl Med       Date:  1993-09

5.  Technetium-99m L,L-ethylenedicysteine clearance and correlation with iodine-125 orthoiodohippurate for the determination of effective renal plasma flow.

Authors:  M Stoffel; F Jamar; C Van Nerom; A Verbruggen; T Besse; J P Squifflet; C Beckers
Journal:  Eur J Nucl Med       Date:  1996-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.